// ============================================================
// Artiva Clinical Sites Dashboard — New Companies Dataset
// Generated: 2026-02-18 via ClinicalTrials.gov API v2
// Companies: Novartis, BMS/Juno, AstraZeneca, Adicet, Sonoma, Dren Bio
// Focus: RA-focused cell therapy and T-cell engager programs
// ============================================================

const newCompaniesData = {

  // ══════════════════════════════════════════════════════════
  // NOVARTIS — PIT565 (T-cell engager for RA)
  // Color: #e67e22 (orange)
  // NCT07029555: Phase 1, Recruiting, Rheumatoid Arthritis
  // ══════════════════════════════════════════════════════════
  novartis: [
    // NCT07029555 — Ascending Dose Study of PIT565 in RA
    {"lat": -34.603, "lon": -58.381, "facility": "Novartis Investigative Site", "city": "Buenos Aires (CABA)", "state": "", "country": "Argentina", "nct": "NCT07029555", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#e67e22", "title": "PIT565 Rheumatoid Arthritis [Phase 1]", "conditions": ["Rheumatoid Arthritis"]},
    {"lat": 42.698, "lon": 23.324, "facility": "Novartis Investigative Site", "city": "Sofia", "state": "", "country": "Bulgaria", "nct": "NCT07029555", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#e67e22", "title": "PIT565 Rheumatoid Arthritis [Phase 1]", "conditions": ["Rheumatoid Arthritis"]},
    {"lat": 39.908, "lon": 116.397, "facility": "Novartis Investigative Site", "city": "Beijing", "state": "", "country": "China", "nct": "NCT07029555", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#e67e22", "title": "PIT565 Rheumatoid Arthritis [Phase 1]", "conditions": ["Rheumatoid Arthritis"]},
    {"lat": 50.929, "lon": 11.590, "facility": "Novartis Investigative Site", "city": "Jena", "state": "Thuringia", "country": "Germany", "nct": "NCT07029555", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#e67e22", "title": "PIT565 Rheumatoid Arthritis [Phase 1]", "conditions": ["Rheumatoid Arthritis"]},
    {"lat": 49.982, "lon": 8.280, "facility": "Novartis Investigative Site", "city": "Mainz", "state": "", "country": "Germany", "nct": "NCT07029555", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#e67e22", "title": "PIT565 Rheumatoid Arthritis [Phase 1]", "conditions": ["Rheumatoid Arthritis"]},
    {"lat": 52.158, "lon": 4.493, "facility": "Novartis Investigative Site", "city": "Leiden", "state": "South Holland", "country": "Netherlands", "nct": "NCT07029555", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#e67e22", "title": "PIT565 Rheumatoid Arthritis [Phase 1]", "conditions": ["Rheumatoid Arthritis"]},
    {"lat": 46.767, "lon": 23.600, "facility": "Novartis Investigative Site", "city": "Cluj-Napoca", "state": "Cluj", "country": "Romania", "nct": "NCT07029555", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#e67e22", "title": "PIT565 Rheumatoid Arthritis [Phase 1]", "conditions": ["Rheumatoid Arthritis"]},
    {"lat": 44.432, "lon": 26.106, "facility": "Novartis Investigative Site", "city": "Bucharest", "state": "", "country": "Romania", "nct": "NCT07029555", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#e67e22", "title": "PIT565 Rheumatoid Arthritis [Phase 1]", "conditions": ["Rheumatoid Arthritis"]},
    {"lat": 42.880, "lon": -8.544, "facility": "Novartis Investigative Site", "city": "Santiago de Compostela", "state": "A Coruña", "country": "Spain", "nct": "NCT07029555", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#e67e22", "title": "PIT565 Rheumatoid Arthritis [Phase 1]", "conditions": ["Rheumatoid Arthritis"]},
    {"lat": 41.389, "lon": 2.159, "facility": "Novartis Investigative Site", "city": "Barcelona", "state": "Catalonia", "country": "Spain", "nct": "NCT07029555", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#e67e22", "title": "PIT565 Rheumatoid Arthritis [Phase 1]", "conditions": ["Rheumatoid Arthritis"]},
    // NCT06335979 — PIT565 in SLE (same drug, autoimmune expansion)
    {"lat": 42.698, "lon": 23.324, "facility": "Novartis Investigative Site", "city": "Sofia", "state": "", "country": "Bulgaria", "nct": "NCT06335979", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#e67e22", "title": "PIT565 Systemic Lupus Erythematosus [Phase 1]", "conditions": ["Systemic Lupus Erythematosus"]},
    {"lat": 39.908, "lon": 116.397, "facility": "Novartis Investigative Site", "city": "Beijing", "state": "", "country": "China", "nct": "NCT06335979", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#e67e22", "title": "PIT565 Systemic Lupus Erythematosus [Phase 1]", "conditions": ["Systemic Lupus Erythematosus"]},
    {"lat": 52.524, "lon": 13.411, "facility": "Novartis Investigative Site", "city": "Berlin", "state": "", "country": "Germany", "nct": "NCT06335979", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#e67e22", "title": "PIT565 Systemic Lupus Erythematosus [Phase 1]", "conditions": ["Systemic Lupus Erythematosus"]},
    {"lat": 49.982, "lon": 8.280, "facility": "Novartis Investigative Site", "city": "Mainz", "state": "", "country": "Germany", "nct": "NCT06335979", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#e67e22", "title": "PIT565 Systemic Lupus Erythematosus [Phase 1]", "conditions": ["Systemic Lupus Erythematosus"]},
    {"lat": 47.498, "lon": 19.040, "facility": "Novartis Investigative Site", "city": "Budapest", "state": "", "country": "Hungary", "nct": "NCT06335979", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#e67e22", "title": "PIT565 Systemic Lupus Erythematosus [Phase 1]", "conditions": ["Systemic Lupus Erythematosus"]}
  ],

  // ══════════════════════════════════════════════════════════
  // BMS/JUNO — CC-97540 / BMS-986353 / Zola-cel (Allo CD19 CAR-T)
  // Color: #9b59b6 (purple)
  // NCT05869955: Breakfree-1, Phase 1, Recruiting — SLE/IIM/SSc/RA
  // ══════════════════════════════════════════════════════════
  bms: [
    // NCT05869955 — Breakfree-1 (includes RA)
    {"lat": 39.729, "lon": -104.832, "facility": "University of Colorado Anschutz Medical Campus", "city": "Aurora", "state": "Colorado", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 39.739, "lon": -104.985, "facility": "Colorado Blood Cancer Institute", "city": "Denver", "state": "Colorado", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 41.308, "lon": -72.928, "facility": "Yale University (Local Institution)", "city": "New Haven", "state": "Connecticut", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 30.332, "lon": -81.656, "facility": "Mayo Clinic in Florida", "city": "Jacksonville", "state": "Florida", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 25.774, "lon": -80.194, "facility": "University of Miami Hospital and Clinics, Sylvester Cancer Center", "city": "Miami", "state": "Florida", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 41.850, "lon": -87.650, "facility": "Local Institution", "city": "Chicago", "state": "Illinois", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 39.290, "lon": -76.612, "facility": "Local Institution", "city": "Baltimore", "state": "Maryland", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 42.358, "lon": -71.060, "facility": "Local Institution (MGH/BWH)", "city": "Boston", "state": "Massachusetts", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 42.263, "lon": -71.802, "facility": "University of Massachusetts Chan Medical School", "city": "Worcester", "state": "Massachusetts", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 42.278, "lon": -83.741, "facility": "University of Michigan", "city": "Ann Arbor", "state": "Michigan", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 42.331, "lon": -83.046, "facility": "Henry Ford Medical Center", "city": "Detroit", "state": "Michigan", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 44.022, "lon": -92.470, "facility": "Mayo Clinic in Rochester, Minnesota", "city": "Rochester", "state": "Minnesota", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 38.627, "lon": -90.198, "facility": "Washington University School of Medicine", "city": "St Louis", "state": "Missouri", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 41.256, "lon": -95.940, "facility": "Local Institution", "city": "Omaha", "state": "Nebraska", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 40.716, "lon": -74.365, "facility": "Atlantic Health System Overlook Medical Center", "city": "Summit", "state": "New Jersey", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 40.714, "lon": -74.006, "facility": "NYU Langone Health", "city": "New York", "state": "New York", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 40.714, "lon": -74.006, "facility": "Icahn School of Medicine at Mount Sinai", "city": "New York", "state": "New York", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 40.714, "lon": -74.006, "facility": "Columbia University Irving Medical Center", "city": "New York", "state": "New York", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 35.913, "lon": -79.056, "facility": "The University of North Carolina at Chapel Hill", "city": "Chapel Hill", "state": "North Carolina", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 41.500, "lon": -81.695, "facility": "Cleveland Clinic", "city": "Cleveland", "state": "Ohio", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 39.961, "lon": -82.999, "facility": "Local Institution", "city": "Columbus", "state": "Ohio", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 32.783, "lon": -96.807, "facility": "UT Southwestern Medical Center", "city": "Dallas", "state": "Texas", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 29.763, "lon": -95.363, "facility": "The University of Texas Health Science Center / MD Anderson Cancer Center", "city": "Houston", "state": "Texas", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 47.606, "lon": -122.332, "facility": "Swedish Medical Center / Fred Hutchinson Cancer Center", "city": "Seattle", "state": "Washington", "country": "United States", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 50.880, "lon": 4.701, "facility": "UZ Leuven", "city": "Leuven", "state": "Flemish Brabant", "country": "Belgium", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 48.584, "lon": 7.746, "facility": "Local Institution", "city": "Strasbourg", "state": "Alsace", "country": "France", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 44.806, "lon": -0.632, "facility": "CHU Bordeaux Haut-Leveque", "city": "Pessac", "state": "Aquitaine", "country": "France", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 43.611, "lon": 3.876, "facility": "CHU Montpellier Lapeyronie Hospital", "city": "Montpellier", "state": "", "country": "France", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 50.634, "lon": 3.055, "facility": "Hopital Claude Huriez - CHU de Lille", "city": "Lille", "state": "", "country": "France", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 43.703, "lon": 7.266, "facility": "Centre Hospitalier Universitaire de Nice", "city": "Nice", "state": "", "country": "France", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 48.853, "lon": 2.349, "facility": "Hôpital Saint-Louis", "city": "Paris", "state": "", "country": "France", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 48.111, "lon": -1.674, "facility": "CHU de Rennes - Hôpital Pontchaillou", "city": "Rennes", "state": "", "country": "France", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 49.794, "lon": 9.951, "facility": "Universitaetsklinikum Wuerzburg", "city": "Würzburg", "state": "Bavaria", "country": "Germany", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 50.933, "lon": 6.950, "facility": "Universitaetsklinikum Koeln", "city": "Cologne", "state": "", "country": "Germany", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 51.340, "lon": 12.371, "facility": "Universitätsklinikum Leipzig", "city": "Leipzig", "state": "Saxony", "country": "Germany", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 52.131, "lon": 11.632, "facility": "Universitaetsklinikum Magdeburg", "city": "Magdeburg", "state": "", "country": "Germany", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 52.524, "lon": 13.411, "facility": "Charité - Universitaetsmedizin Berlin", "city": "Berlin", "state": "", "country": "Germany", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 51.222, "lon": 6.776, "facility": "Universitaetsklinikum Duesseldorf", "city": "Düsseldorf", "state": "", "country": "Germany", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 49.591, "lon": 11.008, "facility": "Universitaetsklinikum Erlangen", "city": "Erlangen", "state": "", "country": "Germany", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 41.892, "lon": 12.511, "facility": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS", "city": "Rome", "state": "Lazio", "country": "Italy", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 45.382, "lon": 9.156, "facility": "Humanitas Research Hospital", "city": "Rozzano", "state": "Milano", "country": "Italy", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 41.389, "lon": 2.159, "facility": "Hospital Universitari Vall d'Hebron", "city": "Barcelona", "state": "Catalonia", "country": "Spain", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 43.466, "lon": -3.805, "facility": "Hospital Universitario Marqués de Valdecilla", "city": "Santander", "state": "Cantabria", "country": "Spain", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 37.892, "lon": -4.773, "facility": "Hospital Universitario Reina Sofia", "city": "Córdoba", "state": "", "country": "Spain", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]},
    {"lat": 36.720, "lon": -4.420, "facility": "H.R.U. Málaga - Hospital General", "city": "Málaga", "state": "", "country": "Spain", "nct": "NCT05869955", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#9b59b6", "title": "CC-97540 (Zola-cel) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathy"]}
  ],

  // ══════════════════════════════════════════════════════════
  // ASTRAZENECA — AZD0120 (GC012F, CD19+BCMA CAR-T for autoimmune)
  // Color: #1abc9c (teal)
  // NCT07295847: Phase 1, Recruiting — SSc/IIM/RA (most RA-relevant)
  // NCT06897930: Phase 1/2, Recruiting — SLE
  // ══════════════════════════════════════════════════════════
  astrazeneca: [
    // NCT07295847 — AZD0120 in Autoimmune Diseases (SSc, IIM, RA)
    {"lat": 32.222, "lon": -110.926, "facility": "Research Site", "city": "Tucson", "state": "Arizona", "country": "United States", "nct": "NCT07295847", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Rheumatoid Arthritis"]},
    {"lat": 37.424, "lon": -122.163, "facility": "Research Site", "city": "Stanford", "state": "California", "country": "United States", "nct": "NCT07295847", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Rheumatoid Arthritis"]},
    {"lat": 41.850, "lon": -87.650, "facility": "Research Site", "city": "Chicago", "state": "Illinois", "country": "United States", "nct": "NCT07295847", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Rheumatoid Arthritis"]},
    {"lat": 42.278, "lon": -83.741, "facility": "Research Site", "city": "Ann Arbor", "state": "Michigan", "country": "United States", "nct": "NCT07295847", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Rheumatoid Arthritis"]},
    {"lat": 38.627, "lon": -90.198, "facility": "Research Site", "city": "St Louis", "state": "Missouri", "country": "United States", "nct": "NCT07295847", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Rheumatoid Arthritis"]},
    {"lat": 40.714, "lon": -74.006, "facility": "Research Site", "city": "New York", "state": "New York", "country": "United States", "nct": "NCT07295847", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Rheumatoid Arthritis"]},
    {"lat": 35.913, "lon": -79.056, "facility": "Research Site", "city": "Chapel Hill", "state": "North Carolina", "country": "United States", "nct": "NCT07295847", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Rheumatoid Arthritis"]},
    {"lat": 47.606, "lon": -122.332, "facility": "Research Site", "city": "Seattle", "state": "Washington", "country": "United States", "nct": "NCT07295847", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Rheumatoid Arthritis"]},
    {"lat": -33.879, "lon": 151.219, "facility": "Research Site", "city": "Darlinghurst (Sydney)", "state": "New South Wales", "country": "Australia", "nct": "NCT07295847", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Rheumatoid Arthritis"]},
    {"lat": -32.907, "lon": 151.726, "facility": "Research Site", "city": "Waratah (Newcastle)", "state": "New South Wales", "country": "Australia", "nct": "NCT07295847", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Rheumatoid Arthritis"]},
    {"lat": 53.551, "lon": 9.993, "facility": "Research Site", "city": "Hamburg", "state": "", "country": "Germany", "nct": "NCT07295847", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Rheumatoid Arthritis"]},
    {"lat": 49.982, "lon": 8.280, "facility": "Research Site", "city": "Mainz", "state": "", "country": "Germany", "nct": "NCT07295847", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Rheumatoid Arthritis"]},
    {"lat": 49.794, "lon": 9.951, "facility": "Research Site", "city": "Würzburg", "state": "", "country": "Germany", "nct": "NCT07295847", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Rheumatoid Arthritis"]},
    {"lat": 41.389, "lon": 2.159, "facility": "Research Site", "city": "Barcelona", "state": "Catalonia", "country": "Spain", "nct": "NCT07295847", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Rheumatoid Arthritis"]},
    {"lat": 40.417, "lon": -3.703, "facility": "Research Site", "city": "Madrid", "state": "", "country": "Spain", "nct": "NCT07295847", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Rheumatoid Arthritis"]},
    {"lat": 55.952, "lon": -3.196, "facility": "Research Site", "city": "Edinburgh", "state": "Scotland", "country": "United Kingdom", "nct": "NCT07295847", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Rheumatoid Arthritis"]},
    {"lat": 51.509, "lon": -0.126, "facility": "Research Site", "city": "London", "state": "", "country": "United Kingdom", "nct": "NCT07295847", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Autoimmune Diseases incl. RA [Phase 1]", "conditions": ["Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Rheumatoid Arthritis"]},
    // NCT06897930 — AZD0120 in SLE
    {"lat": 37.775, "lon": -122.419, "facility": "Research Site", "city": "San Francisco", "state": "California", "country": "United States", "nct": "NCT06897930", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Systemic Lupus Erythematosus [Phase 1/2]", "conditions": ["Lupus Erythematosus, Systemic"]},
    {"lat": 27.948, "lon": -82.458, "facility": "Research Site", "city": "Tampa", "state": "Florida", "country": "United States", "nct": "NCT06897930", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Systemic Lupus Erythematosus [Phase 1/2]", "conditions": ["Lupus Erythematosus, Systemic"]},
    {"lat": 33.749, "lon": -84.388, "facility": "Research Site", "city": "Atlanta", "state": "Georgia", "country": "United States", "nct": "NCT06897930", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Systemic Lupus Erythematosus [Phase 1/2]", "conditions": ["Lupus Erythematosus, Systemic"]},
    {"lat": 38.981, "lon": -77.100, "facility": "Research Site (NIH area)", "city": "Bethesda", "state": "Maryland", "country": "United States", "nct": "NCT06897930", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Systemic Lupus Erythematosus [Phase 1/2]", "conditions": ["Lupus Erythematosus, Systemic"]},
    {"lat": 43.048, "lon": -76.147, "facility": "Research Site", "city": "Syracuse", "state": "New York", "country": "United States", "nct": "NCT06897930", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Systemic Lupus Erythematosus [Phase 1/2]", "conditions": ["Lupus Erythematosus, Systemic"]},
    {"lat": 35.227, "lon": -80.843, "facility": "Research Site", "city": "Charlotte", "state": "North Carolina", "country": "United States", "nct": "NCT06897930", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Systemic Lupus Erythematosus [Phase 1/2]", "conditions": ["Lupus Erythematosus, Systemic"]},
    {"lat": 37.554, "lon": -77.460, "facility": "Research Site", "city": "Richmond", "state": "Virginia", "country": "United States", "nct": "NCT06897930", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Systemic Lupus Erythematosus [Phase 1/2]", "conditions": ["Lupus Erythematosus, Systemic"]},
    {"lat": -37.814, "lon": 144.963, "facility": "Research Site", "city": "Melbourne", "state": "Victoria", "country": "Australia", "nct": "NCT06897930", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#1abc9c", "title": "AZD0120 (GC012F) Systemic Lupus Erythematosus [Phase 1/2]", "conditions": ["Lupus Erythematosus, Systemic"]}
  ],

  // ══════════════════════════════════════════════════════════
  // ADICET THERAPEUTICS — ADI-001 (Gamma Delta CAR-T)
  // Color: #e74c3c (red)
  // NCT06375993: Phase 1, Recruiting — Autoimmune (SLE, SSc, AAV, etc.)
  // NCT07100873: Phase 1, Recruiting — Rheumatoid Arthritis (China)
  // ══════════════════════════════════════════════════════════
  adicet: [
    // NCT06375993 — ADI-001 in Autoimmune Disease
    {"lat": 37.485, "lon": -122.236, "facility": "Adicet Clinical Trials", "city": "Redwood City", "state": "California", "country": "United States", "nct": "NCT06375993", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#e74c3c", "title": "ADI-001 Autoimmune Diseases [Phase 1]", "conditions": ["Lupus Nephritis", "Systemic Lupus Erythematosus", "Systemic Sclerosis", "ANCA-Associated Vasculitis", "Idiopathic Inflammatory Myopathies", "Stiff Person Syndrome"]},
    {"lat": 42.886, "lon": -78.878, "facility": "Roswell Park Comprehensive Cancer Center", "city": "Buffalo", "state": "New York", "country": "United States", "nct": "NCT06375993", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#e74c3c", "title": "ADI-001 Autoimmune Diseases [Phase 1]", "conditions": ["Lupus Nephritis", "Systemic Lupus Erythematosus", "Systemic Sclerosis", "ANCA-Associated Vasculitis", "Idiopathic Inflammatory Myopathies", "Stiff Person Syndrome"]},
    // NCT07100873 — ADI-001 in Rheumatoid Arthritis (China)
    {"lat": 31.222, "lon": 121.458, "facility": "Adicet Clinical Trials", "city": "Shanghai", "state": "Shanghai", "country": "China", "nct": "NCT07100873", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#e74c3c", "title": "ADI-001 Rheumatoid Arthritis [Phase 1]", "conditions": ["Rheumatoid Arthritis"]}
  ],

  // ══════════════════════════════════════════════════════════
  // SONOMA BIOTHERAPEUTICS — SBT777101 (Treg cell therapy)
  // Color: #2ecc71 (green)
  // NCT06201416: Phase 1, Recruiting — Rheumatoid Arthritis
  // NCT07123038: LTFU Observational, Recruiting — RA + HS
  // ══════════════════════════════════════════════════════════
  sonoma: [
    // NCT06201416 — SBT777101 in Rheumatoid Arthritis (primary RA trial)
    {"lat": 33.509, "lon": -111.899, "facility": "Mayo Clinic", "city": "Scottsdale", "state": "Arizona", "country": "United States", "nct": "NCT06201416", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#2ecc71", "title": "SBT777101 Rheumatoid Arthritis [Phase 1]", "conditions": ["Rheumatoid Arthritis"]},
    {"lat": 37.775, "lon": -122.419, "facility": "UCSF Medical Center", "city": "San Francisco", "state": "California", "country": "United States", "nct": "NCT06201416", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#2ecc71", "title": "SBT777101 Rheumatoid Arthritis [Phase 1]", "conditions": ["Rheumatoid Arthritis"]},
    {"lat": 37.424, "lon": -122.163, "facility": "Stanford Medical Center", "city": "Stanford", "state": "California", "country": "United States", "nct": "NCT06201416", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#2ecc71", "title": "SBT777101 Rheumatoid Arthritis [Phase 1]", "conditions": ["Rheumatoid Arthritis"]},
    {"lat": 39.729, "lon": -104.832, "facility": "University of Colorado", "city": "Aurora", "state": "Colorado", "country": "United States", "nct": "NCT06201416", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#2ecc71", "title": "SBT777101 Rheumatoid Arthritis [Phase 1]", "conditions": ["Rheumatoid Arthritis"]},
    {"lat": 41.850, "lon": -87.650, "facility": "Northwestern University", "city": "Chicago", "state": "Illinois", "country": "United States", "nct": "NCT06201416", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#2ecc71", "title": "SBT777101 Rheumatoid Arthritis [Phase 1]", "conditions": ["Rheumatoid Arthritis"]},
    {"lat": 42.358, "lon": -71.060, "facility": "Tufts University", "city": "Boston", "state": "Massachusetts", "country": "United States", "nct": "NCT06201416", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#2ecc71", "title": "SBT777101 Rheumatoid Arthritis [Phase 1]", "conditions": ["Rheumatoid Arthritis"]},
    {"lat": 42.358, "lon": -71.060, "facility": "Massachusetts General Hospital", "city": "Boston", "state": "Massachusetts", "country": "United States", "nct": "NCT06201416", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#2ecc71", "title": "SBT777101 Rheumatoid Arthritis [Phase 1]", "conditions": ["Rheumatoid Arthritis"]},
    {"lat": 42.358, "lon": -71.060, "facility": "Brigham and Women's Hospital", "city": "Boston", "state": "Massachusetts", "country": "United States", "nct": "NCT06201416", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#2ecc71", "title": "SBT777101 Rheumatoid Arthritis [Phase 1]", "conditions": ["Rheumatoid Arthritis"]},
    // NCT07123038 — Treg LTFU study (RA + HS)
    {"lat": 37.775, "lon": -122.419, "facility": "UCSF Medical Center", "city": "San Francisco", "state": "California", "country": "United States", "nct": "NCT07123038", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#2ecc71", "title": "SBT777101 Treg LTFU — RA & Hidradenitis Suppurativa [Observational]", "conditions": ["Rheumatoid Arthritis", "Hidradenitis Suppurativa"]},
    {"lat": 37.424, "lon": -122.163, "facility": "Stanford Medical Center", "city": "Stanford", "state": "California", "country": "United States", "nct": "NCT07123038", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#2ecc71", "title": "SBT777101 Treg LTFU — RA & Hidradenitis Suppurativa [Observational]", "conditions": ["Rheumatoid Arthritis", "Hidradenitis Suppurativa"]},
    {"lat": 39.729, "lon": -104.832, "facility": "University of Colorado", "city": "Aurora", "state": "Colorado", "country": "United States", "nct": "NCT07123038", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#2ecc71", "title": "SBT777101 Treg LTFU — RA & Hidradenitis Suppurativa [Observational]", "conditions": ["Rheumatoid Arthritis", "Hidradenitis Suppurativa"]},
    {"lat": 41.850, "lon": -87.650, "facility": "Northwestern University", "city": "Chicago", "state": "Illinois", "country": "United States", "nct": "NCT07123038", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#2ecc71", "title": "SBT777101 Treg LTFU — RA & Hidradenitis Suppurativa [Observational]", "conditions": ["Rheumatoid Arthritis", "Hidradenitis Suppurativa"]},
    {"lat": 42.358, "lon": -71.060, "facility": "Boston Academic Medical Centers (Tufts/MGH/BWH)", "city": "Boston", "state": "Massachusetts", "country": "United States", "nct": "NCT07123038", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#2ecc71", "title": "SBT777101 Treg LTFU — RA & Hidradenitis Suppurativa [Observational]", "conditions": ["Rheumatoid Arthritis", "Hidradenitis Suppurativa"]},
    {"lat": 44.980, "lon": -93.264, "facility": "University of Minnesota", "city": "Minneapolis", "state": "Minnesota", "country": "United States", "nct": "NCT07123038", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#2ecc71", "title": "SBT777101 Treg LTFU — RA & Hidradenitis Suppurativa [Observational]", "conditions": ["Rheumatoid Arthritis", "Hidradenitis Suppurativa"]},
    {"lat": 35.994, "lon": -78.899, "facility": "Duke University", "city": "Durham", "state": "North Carolina", "country": "United States", "nct": "NCT07123038", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#2ecc71", "title": "SBT777101 Treg LTFU — RA & Hidradenitis Suppurativa [Observational]", "conditions": ["Rheumatoid Arthritis", "Hidradenitis Suppurativa"]},
    {"lat": 29.763, "lon": -95.363, "facility": "The University of Texas MD Anderson Cancer Center", "city": "Houston", "state": "Texas", "country": "United States", "nct": "NCT07123038", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#2ecc71", "title": "SBT777101 Treg LTFU — RA & Hidradenitis Suppurativa [Observational]", "conditions": ["Rheumatoid Arthritis", "Hidradenitis Suppurativa"]}
  ],

  // ══════════════════════════════════════════════════════════
  // DREN BIO — DR-0201 (CD19-targeting bispecific, autoimmune)
  // Color: #f39c12 (gold)
  // NCT06647069: Phase 1, Recruiting — SLE, CLE, Sjogren's, DM, SSc
  // ══════════════════════════════════════════════════════════
  dren: [
    // NCT06647069 — DR-0201 in Autoimmune Diseases
    {"lat": -27.493, "lon": 153.058, "facility": "Dren Investigational Site", "city": "Coorparoo (Brisbane)", "state": "Queensland", "country": "Australia", "nct": "NCT06647069", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#f39c12", "title": "DR-0201 Autoimmune Diseases [Phase 1]", "conditions": ["SLE", "Cutaneous Lupus", "Sjogren's Syndrome", "Dermatomyositis", "Polymyositis", "Systemic Sclerosis"]},
    {"lat": -37.814, "lon": 144.963, "facility": "Dren Investigational Site", "city": "Melbourne", "state": "Victoria", "country": "Australia", "nct": "NCT06647069", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#f39c12", "title": "DR-0201 Autoimmune Diseases [Phase 1]", "conditions": ["SLE", "Cutaneous Lupus", "Sjogren's Syndrome", "Dermatomyositis", "Polymyositis", "Systemic Sclerosis"]},
    {"lat": 43.343, "lon": 17.808, "facility": "Dren Investigational Site", "city": "Mostar", "state": "", "country": "Bosnia and Herzegovina", "nct": "NCT06647069", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#f39c12", "title": "DR-0201 Autoimmune Diseases [Phase 1]", "conditions": ["SLE", "Cutaneous Lupus", "Sjogren's Syndrome", "Dermatomyositis", "Polymyositis", "Systemic Sclerosis"]},
    {"lat": 43.849, "lon": 18.356, "facility": "Dren Investigational Site", "city": "Sarajevo", "state": "", "country": "Bosnia and Herzegovina", "nct": "NCT06647069", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#f39c12", "title": "DR-0201 Autoimmune Diseases [Phase 1]", "conditions": ["SLE", "Cutaneous Lupus", "Sjogren's Syndrome", "Dermatomyositis", "Polymyositis", "Systemic Sclerosis"]},
    {"lat": -36.849, "lon": 174.763, "facility": "Dren Investigational Site", "city": "Auckland", "state": "", "country": "New Zealand", "nct": "NCT06647069", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#f39c12", "title": "DR-0201 Autoimmune Diseases [Phase 1]", "conditions": ["SLE", "Cutaneous Lupus", "Sjogren's Syndrome", "Dermatomyositis", "Polymyositis", "Systemic Sclerosis"]},
    {"lat": -25.745, "lon": 28.188, "facility": "Dren Investigational Site", "city": "Pretoria", "state": "Gauteng", "country": "South Africa", "nct": "NCT06647069", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#f39c12", "title": "DR-0201 Autoimmune Diseases [Phase 1]", "conditions": ["SLE", "Cutaneous Lupus", "Sjogren's Syndrome", "Dermatomyositis", "Polymyositis", "Systemic Sclerosis"]},
    {"lat": -23.904, "lon": 29.469, "facility": "Dren Investigational Site", "city": "Polokwane", "state": "Limpopo", "country": "South Africa", "nct": "NCT06647069", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#f39c12", "title": "DR-0201 Autoimmune Diseases [Phase 1]", "conditions": ["SLE", "Cutaneous Lupus", "Sjogren's Syndrome", "Dermatomyositis", "Polymyositis", "Systemic Sclerosis"]},
    {"lat": -26.673, "lon": 27.926, "facility": "Dren Investigational Site", "city": "Vereeniging", "state": "Gauteng", "country": "South Africa", "nct": "NCT06647069", "status": "RECRUITING", "site_status": "RECRUITING", "color": "#f39c12", "title": "DR-0201 Autoimmune Diseases [Phase 1]", "conditions": ["SLE", "Cutaneous Lupus", "Sjogren's Syndrome", "Dermatomyositis", "Polymyositis", "Systemic Sclerosis"]}
  ]

};

// Export for use in dashboard
if (typeof module !== 'undefined' && module.exports) {
  module.exports = newCompaniesData;
}
